ECJ JUDGMENT OF 11 SEPTEMBER 2007 – MERCK GENERICOS-PRODUTOS FARMACÊUTICOS, CASE C-431/05 – WORLD TRADE ORGANISATION – AGREEMENT ON TRADE-RELATED ASPECTS OF INTELLECTUAL PROPERTY RIGHTS (TRIPS) – PATENTS – JURISDICTION OF THE COURT – DIRECT EFFECT
Keywords:
Article 33 of TRIPs Agreement – Patents – Minimum term of protectionAbstract
In this case the ECJ deals with the question of its jurisdiction to interpret Article 33 of the TRIPs Agreement under a preliminary ruling. For the Court, since the Community has not yet exercised its powers in the sphere of patents or, at the very least, at internal level, that exercise has not to date been of sufficient importance, one should conclude that Article 33 of the TRIPs Agreement forms part of a sphere in which, at the present point in the development of Community law, the Member States remain principally competent. In these circumstances, as Community legislation in the sphere of patents now stands, it is not contrary to Community law for Article 33 of the TRIPs Agreement to be directly applied by a national court subject to the conditions provided for by national law. This comment suggests that this case-law clarifies the basis and scope of the ECJ’s jurisdiction. It is plausible to understand that the Court will never decline its formal jurisdiction on admissibility, which constitutes the foundation of the monopoly of the Court to decide on the vertical distribution of powers between the EC and its Members States. The jurisdiction of the Court to exercise its interpretation on a particular subject matter, on the other hand, depends on the existence of relevant Community law.Downloads
Published
2009-01-29
Issue
Section
CASE LAW COURT OF JUSTICE OF THE EUROPEAN COMMUNITIES
License
Copyright
Submission of a manuscript to the RDCE implies having read and accepted the journal's editorial guidelines and instructions for authors. When a work is accepted for publication, it is understood that the author grants the RDCE exclusive rights of reproduction, distribution and, where appropriate, sale of his manuscript for exploitation in all countries of the world in printed version, as well as any other magnetic, optical and digital media.
Authors shall transfer the publishing rights of their manuscript to RDCE so that it may be disseminated and capitalised on Intranets, the Internet and any web portals and wireless devices that the publisher may decide, by placing it at the disposal of users so that the latter may consult it online and extract content from it, print it and/or download and save it. These activities must comply with the terms and conditions outlined on the website hosting the work. However, the RDCE authorises authors of papers published in the journal to include a copy of these papers, once published, on their personal websites and/or other open access digital repositories. Copies must include a specific mention of RDCE, citing the year and issue of the journal in which the article was published, and adding a link to the RDCE website(s).
A year after its publication, the works of the RDCE will be under the Creative Commons Attribution-Noncommercial-NoDerivative 4.0 International license (CC BY-NC-ND 4.0), which allows third parties to share the work as long as its author and its first publication is indicated, without the right to commercial exploitation and the elaboration of derivative works.
Plagiarism and scientific fraud
The publication of work that infringes on intellectual property rights is the sole responsibility of the authors, including any conflicts that may occur regarding infringement of copyright. This includes, most importantly, conflicts related to the commission of plagiarism and/or scientific fraud.
Practices constituting scientific plagiarism are as follows:
1. Presenting the work of others as your own.
2. Adopting words or ideas from other authors without due recognition.
3. Not using quotation marks or another distinctive format to distinguish literal quotations.
4. Giving incorrect information about the true source of a citation.
5. The paraphrasing of a source without mentioning the source.
6. Excessive paraphrasing, even if the source is mentioned.
Practices constituting scientific fraud are as follows:
1. Fabrication, falsification or omission of data and plagiarism.
2. Duplicate publication.
3. Conflicts of authorship.
Warning
Any breach of these Rules shall constitute a ground for rejection of the manuscript submitted.